NASDAQ:LUNG
Pulmonx Corp
Pulmonx Corp's revenue grew 8.0% in fiscal 2025 to $90.5M while operating margin rose to −59.3%. Free cash flow was −$32.8M, −36.3% of revenue, and the diluted share count rose 4.0%.Summary generated from Pulmonx Corp's SEC filings. Latest annual report filed Mar 10, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$90.5M
Revenue growth+8.0%
Revenue, 5-yr CAGR+22.6%
Gross margin74.2%
Operating margin−59.3%
Net margin−59.7%
ROIC−110.4%
Return on equity−77.2%
Debt / equity0.69
Free cash flow−$32.8M
FCF margin−36.3%
Share count change+4.0%
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 48 | 54 | 69 | 84 | 90 |
| Operating income | −47 | −59 | −62 | −58 | −54 |
| Net income | −49 | −59 | −61 | −56 | −54 |
| Free cash flow | −45 | −46 | −38 | −33 | −33 |
Recent filings
- 4Insider transaction report
Sep 3, 2026 - 4Insider transaction report
Sep 3, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Aug 4, 2026 - 8-KResults of operations and financial condition
Jul 29, 2026 - 8-KResults of a shareholder vote
Jun 4, 2026 - 10-QQuarterly report for the period ended Mar 31, 2026
May 4, 2026 - 8-KResults of operations and financial condition
Apr 29, 2026 - DEF 14AProxy statement
Apr 22, 2026